P. Jezequel et al., Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations, MOL HUM REP, 6(12), 2000, pp. 1063-1067
Many studies have shown that congenital absence of the vas deferens (CAVD)
is a genital cystic fibrosis transmembrane conductance regulator (CFTR)-med
iated phenotype, with a broad spectrum of abnormalities causing male infert
ility. The genotype of these patients includes mutations in the CFTR gene,
e.g. Delta F508, R117H and the T5 allele; all of which are commonly found i
n CAVD. In this study we have screened the entirety of CFTR gene in 47 male
s with anomalies of the vas deferens: 37 cases of congenital bilateral abse
nce of the vas deferens, three cases of congenital unilateral absence of th
e vas deferens and seven cases of obstructive azoospermia with hypoplastic
vas deferens. Among the 94 chromosomes studied, 65 mutations, of which thre
e are novel (2789 + 2insA, L1227S, 4428insGA), were identified. The majorit
y of patients (63.8%) had two detectable CFTR gene mutations. Furthermore,
high frequencies of the Delta F508 mutation (44.7%), the T5 allele (36.2%)
and R117H mutation (19.1%) were observed.